L-Carnitine’s Role in Modulating COVID-19
The COVID-19 pandemic has highlighted the need for effective treatments and supplements.
A recent pilot study examined the potential of L-carnitine in modulating the effects of SARS-CoV-2 infection. This post summarizes the findings of this study.
Study Overview
The study, conducted by researchers in Brazil, was a double-blind, placebo-controlled trial involving 223 participants. It aimed to evaluate the safety and efficacy of L-carnitine L-tartrate in individuals at risk of SARS-CoV-2 infection or those with mild COVID-19 symptoms.
Key Findings
- Reduction in Inflammation: L-carnitine supplementation was associated with reduced inflammatory markers and improved lung lesions in COVID-19 patients.
- Improved Coagulation Profiles: The study found that L-carnitine helped modulate coagulation pathways, which is crucial in preventing complications in COVID-19 patients.
- Dosage: Participants received 2 grams of L-carnitine L-tartrate daily for 21 days.
Safety and Side Effects
The supplementation was well-tolerated, with common adverse events being mild, such as headaches and tiredness.
Conclusion
L-carnitine shows potential in reducing inflammation and improving lung health in COVID-19 patients. While further research is needed, these findings are promising. Access the full study here.
Injectify
Injectable L-Carnitine
5.0 / 5.0
(7) 7 total reviews
- FAST Shipping
- Secure Checkout
- 100% PURE Carnitine
Share
Disclaimer
FDA Disclaimer
The information presented on this website has not been reviewed or approved by the U.S. Food and Drug Administration. Any statements about our products are not intended to diagnose, treat, cure, or prevent any disease.
Research Use Only
All products sold by Injectify.is are intended solely for laboratory and research applications. They are not approved for human or veterinary use, nor are they available for purchase by or use on patients.
Not a Compounding Facility
Injectify.is operates exclusively as a chemical supplier and does not meet the definitions of a compounding pharmacy or chemical compounding facility under Section 503A of the Federal Food, Drug, and Cosmetic Act. Furthermore, Injectify.is is not an outsourcing facility as defined by Section 503B of the same Act.
Terms & Conditions
Before placing an order, please review our Terms & Conditions. By purchasing from Injectify.is, you acknowledge and agree to abide by these terms.